Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
暂无分享,去创建一个
[1] G. Feldmann,et al. The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer , 2009, Gut.
[2] L. Cope,et al. HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma , 2009, Modern Pathology.
[3] J. Heverhagen,et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer , 2009, Gut.
[4] M. le Gall,et al. GLUT2 mutations, translocation, and receptor function in diet sugar managing. , 2009, American journal of physiology. Endocrinology and metabolism.
[5] F. Real,et al. FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[6] G. Feldmann,et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. , 2008, Gastroenterology.
[7] M. Malafa,et al. PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms , 2008, Annals of Surgical Oncology.
[8] G. Feldmann,et al. Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. , 2008, The Journal of molecular diagnostics : JMD.
[9] F. Chierichetti,et al. 18-Fluorodeoxyglucose Positron Emission Tomography Enhances Computed Tomography Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2007, Annals of surgery.
[10] J. Lee,et al. The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic Cancer , 2006, Journal of clinical gastroenterology.
[11] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[12] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[13] J. Best,et al. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.
[14] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[15] M. Kalra,et al. Role of dual PET/CT scanning in abdominal malignancies , 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.
[16] C. Pinson,et al. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. , 2004, Journal of hepato-biliary-pancreatic surgery.
[17] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[18] R H Hruban,et al. Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.
[19] V. R. McCready,et al. FDG accumulation and tumor biology. , 1998, Nuclear medicine and biology.
[20] R. Hruban,et al. Pancreatic cancer in mice and man: the Penn Workshop 2004. , 2006, Cancer research.
[21] E. Furth,et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.
[22] T. A. Smith,et al. Mammalian hexokinases and their abnormal expression in cancer. , 2000, British journal of biomedical science.